| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1053/J.GASTRO.2016.02.011 |
| P698 | PubMed publication ID | 27147122 |
| P50 | author | Jan Tack | Q41315671 |
| Nicholas Talley | Q7026286 | ||
| P2093 | author name string | Hidekazu Suzuki | |
| Vincenzo Stanghellini | |||
| Francis K L Chan | |||
| Juan R Malagelada | |||
| William L Hasler | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1380-1392 | |
| P577 | publication date | 2016-05-01 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | Gastroduodenal Disorders | |
| P478 | volume | 150 |
| Q49971426 | "First Do No Harm": Adverse Events from Pharmaceutical Treatment of Gastroparesis and Dyspepsia. |
| Q91894982 | A Combination of Peppermint Oil and Caraway Oil for the Treatment of Functional Dyspepsia: A Systematic Review and Meta-Analysis |
| Q55234456 | A Critical Review of the Current Clinical Landscape of Gastroparesis. |
| Q64238201 | A Novel, Duodenal-Release Formulation of a Combination of Caraway Oil and L-Menthol for the Treatment of Functional Dyspepsia: A Randomized Controlled Trial |
| Q50067221 | A Randomized Double-Blind, Placebo-Controlled, Cross-Over Study Using Baclofen in the Treatment of Rumination Syndrome |
| Q36388700 | A magnetic resonance imaging study of gastric motor function in patients with dyspepsia associated with Ehlers-Danlos Syndrome-Hypermobility Type: A feasibility study. |
| Q47148113 | A non-interventional, observational study of a fixed combination of pepsin and amino acid hydrochloride in patients with functional dyspepsia. |
| Q40378087 | ACG Clinical Guideline: Treatment of Helicobacter pylori Infection |
| Q39385451 | ACG and CAG Clinical Guideline: Management of Dyspepsia |
| Q54967207 | Abundance of Enterobacteriaceae in the colon mucosa in diverticular disease. |
| Q53700128 | Activation of Eosinophils and Mast Cells in Functional Dyspepsia: an Ultrastructural Evaluation. |
| Q89113170 | Analysis of Nausea in Clinical Studies of Lubiprostone for the Treatment of Constipation Disorders |
| Q96304045 | Anhedonia and functional dyspepsia in obese patients: Relationship with binge eating behaviour |
| Q90623162 | Balancing Act: The Need for Work Style Reform for Young and/or Female Gastroenterologists |
| Q64120583 | Biological Response to Meal Ingestion: Gender Differences |
| Q55402359 | Burden of impaired sleep quality on work productivity in functional dyspepsia. |
| Q92069143 | Buspirone for the Management of Functional Dyspepsia With Rapid Gastric Emptying |
| Q95728322 | CYP2C19 Genotype, CagA Genotype and Antibiotic Resistant Strain of Helicobacter pylori Infection |
| Q48306528 | Centrally Targeted Pharmacotherapy for Chronic Abdominal Pain: Understanding and Management |
| Q38813162 | Chronic Unexplained Nausea and Vomiting or Gastric Neuromuscular Dysfunction (GND)? An Update on Nomenclature, Pathophysiology and Treatment, and Relationship to Gastroparesis |
| Q92124581 | Chronic unexplained nausea in adults: Prevalence, impact on quality of life, and underlying organic diseases in a cohort of 5096 subjects comprehensively investigated |
| Q92518761 | Clinical Practice Guidelines for Functional Dyspepsia in Korea |
| Q48087978 | Clinical characteristics of functional dyspepsia depending on chemosensitivity to capsaicin. |
| Q92860820 | Clinical course of biliary-type sphincter of Oddi dysfunction: endoscopic sphincterotomy and functional dyspepsia as affecting factors |
| Q64112839 | Combination of 15 lipid metabolites and motilin to diagnose spleen-deficiency FD |
| Q49474909 | Complementary and alternative treatment in functional dyspepsia |
| Q99628352 | Correlation between lifestyle and social factors in functional dyspepsia among college freshmen |
| Q38660538 | Cyclic vomiting syndrome is a prevalent and under-recognized condition in the gastroenterology outpatient clinic |
| Q93043225 | Cyclic vomiting syndrome: Pathophysiology, comorbidities, and future research directions |
| Q51742582 | Cyclic vomiting syndrome: diagnostic approach and current management strategies. |
| Q50016783 | Cyclic vomiting syndrome: epidemiology, diagnosis, and treatment |
| Q60956879 | DA-9701 (Motilitone): A Multi-Targeting Botanical Drug for the Treatment of Functional Dyspepsia |
| Q93011506 | Development of a quantitative method for evaluating small intestinal motility using ultrasonography in mice |
| Q53083035 | Diabetes and the Stomach. |
| Q92629108 | Diabetic Gastroparesis: Perspectives From a Patient and Health Care Providers |
| Q64087629 | Diagnosis and Treatment of Rumination Syndrome: A Critical Review |
| Q48104432 | Diagnosis of gastro-oesophageal reflux disease is enhanced by adding oesophageal histology and excluding epigastric pain. |
| Q52815301 | Diagnosis: Rome IV criteria for FGIDs - an improvement or more of the same? |
| Q89848548 | Diet and functional dyspepsia: Clinical correlates and therapeutic perspectives |
| Q100635425 | Duodenal acidification induces gastric relaxation and alters epithelial barrier function by a mast cell independent mechanism |
| Q46450046 | Early satiety and postprandial fullness in gastroparesis correlate with gastroparesis severity, gastric emptying, and water load testing. |
| Q39042056 | Editorial: Moving Away From Focussing on Gastric Pathophysiology in Functional Dyspepsia: New Insights and Therapeutic Implications |
| Q50117924 | Effect of Zhizhu Kuanzhong capsule on functional dyspepsia: Protocol for a systematic review and meta-analysis of randomized controlled trials |
| Q42371575 | Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression |
| Q47283483 | Effects of Antidepressants on Gastric Function in Patients with Functional Dyspepsia |
| Q47653483 | Effects of meal palatability on postprandial sensations |
| Q91637936 | Efficacy Comparison of Different Acupuncture Treatments for Functional Dyspepsia: A Systematic Review with Network Meta-Analysis |
| Q48097443 | Efficacy and safety of Modified Tongxie Yaofang in diarrhea-predominant irritable bowel syndrome management: A meta-analysis of randomized, positive medicine-controlled trials. |
| Q61446684 | Efficacy of acupuncture versus sham acupuncture for postprandial distress syndrome: study protocol for a randomized controlled trial |
| Q92640088 | Efficacy of compatible acupoints and single acupoint versus sham acupuncture for functional dyspepsia: study protocol for a randomized controlled trial |
| Q89678016 | Efficacy of prebiotics and probiotics for functional dyspepsia: A systematic review and meta-analysis |
| Q47669922 | Emergency Department Burden of Nausea and Vomiting Associated With Cannabis Use Disorder: US Trends From 2006 to 2013. |
| Q92557559 | Emerging Role of Aprepitant in Cannabis Hyperemesis Syndrome |
| Q64935962 | Emphysematous Gastritis in a Patient with Untreated Cyclic Vomiting Syndrome. |
| Q89704729 | Endoscopic yield of chronic dyspepsia in outpatients: A single-center experience in Cambodia |
| Q33635123 | Endoscopy-Guided Evaluation of Duodenal Mucosal Permeability in Functional Dyspepsia |
| Q50207278 | Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study |
| Q98612736 | Epigastric pain syndrome: What can traditional Chinese medicine do? A randomized controlled trial of Biling Weitong Granules |
| Q42031862 | Epigastric symptoms of gallbladder dyskinesia mistaken for functional dyspepsia: Retrospective observational study |
| Q89634346 | Epstein-Barr Virus and Helicobacter Pylori Co-Infection in Non-Malignant Gastroduodenal Disorders |
| Q52603772 | Expert consensus document: Advances in the diagnosis and classification of gastric and intestinal motility disorders. |
| Q98946400 | Fifty-eight-year-old female with abdominal migraine: A rare cause of episodic gastrointestinal disturbance in adults |
| Q58087674 | Functional Dyspepsia: Clinical Symptoms, Psychological Findings, and GCSI Scores |
| Q99402809 | Functional Dyspesia |
| Q50110085 | Functional Gastrointestinal Disorders: Complex Treatments for Complex Pathophysiological Mechanisms |
| Q57653128 | Functional dyspepsia |
| Q57789296 | Functional dyspepsia |
| Q100530208 | Functional dyspepsia |
| Q47691689 | Functional dyspepsia and duodenal eosinophilia: A new model |
| Q100530205 | Functional gastrointestinal disorders: advances in understanding and management |
| Q91780717 | Gastric Emptying Scintigraphy: Beyond Numbers - An Observational Study to Differentiate between Various Etiologies and a Step toward Personalized Management |
| Q47775655 | Gastric Motor Dysfunction in Patients With Functional Gastroduodenal Symptoms |
| Q48336487 | Gastric accommodation in healthy subjects studied by ultrasound, manometry, and impedancemetry |
| Q49370174 | Gastric bacterial Flora in patients Harbouring Helicobacter pylori with or without chronic dyspepsia: analysis with matrix-assisted laser desorption ionization time-of-flight mass spectroscopy |
| Q58759929 | Gastric corticotropin-releasing factor influences mast cell infiltration in a rat model of functional dyspepsia |
| Q58541866 | Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders |
| Q38967184 | Gastrointestinal Transit Assessment: Role of Scintigraphy: Where Are We Now? Where Are We Going? |
| Q58570237 | Gastroparesis |
| Q60923122 | Gastroparesis and Functional Dyspepsia: A Blurring Distinction of Pathophysiology and Treatment |
| Q90347934 | Gastroparesis: a turning point in understanding and treatment |
| Q93043253 | Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association |
| Q91994665 | Gut-focused hypnotherapy for Functional Gastrointestinal Disorders: Evidence-base, practical aspects, and the Manchester Protocol |
| Q64052966 | Helicobacter pylori Vacuolating Cytotoxin A Causes Anorexia and Anxiety via Hypothalamic Urocortin 1 in Mice |
| Q54412390 | Helicobacter pylori-Associated Upper Gastrointestinal Symptoms: FD or HpD? |
| Q90011065 | Hellenic consensus on Helicobacter pylori infection |
| Q94339370 | Herbal (non‐Chinese) medicines for functional dyspepsia |
| Q54997827 | Higher frequency of upper gastrointestinal symptoms in healthy young Japanese females compared to males and older generations. |
| Q58549808 | Hybrid endoluminal stapled pyloroplasty: an alternative treatment option for gastric outlet obstruction syndrome |
| Q47619708 | Identification and validation of functional gastrointestinal disorder subtypes using latent class analysis: a population-based study |
| Q52658319 | Identification of Individuals with Functional Dyspepsia With a Simple, Minimally Invasive Test: A Single Center Cohort Study of the Oral Capsaicin Test. |
| Q57153930 | Immunopathological and molecular basis of functional dyspepsia and current therapeutic approaches |
| Q58694782 | Influence of cigarette smoking on the human duodenal mucosa-associated microbiota |
| Q58409793 | Insights into the evaluation and management of dyspepsia: recent developments and new guidelines |
| Q89327267 | Katie: The Physician's Perspective of a Young Woman's Illness Experience |
| Q47804431 | Long-term safety and efficacy of acotiamide in functional dyspepsia (postprandial distress syndrome)-results from the European phase 3 open-label safety trial. |
| Q58582312 | Low-dose imipramine for refractory functional dyspepsia: a randomised, double-blind, placebo-controlled trial |
| Q47855083 | Management of functional dyspepsia: state of the art and emerging therapies |
| Q90731485 | Meeting Summary: 2019 James W. Freston Conference: Food at the Intersection of Gut Health and Disease |
| Q58554827 | Migraine, Cyclic Vomiting Syndrome, and Other Gastrointestinal Disorders |
| Q39101083 | Minimal differences in prevalence and spectrum of organic disease at upper gastrointestinal endoscopy between selected secondary care patients with symptoms of gastro-oesophageal reflux or dyspepsia |
| Q89586336 | Minimally Invasive Surgical Approach for the Treatment of Superior Mesenteric Artery Syndrome: Long-Term Outcomes |
| Q92127906 | Nerve growth factor and Tropomyosin receptor kinase A are increased in the gastric mucosa of patients with functional dyspepsia |
| Q96304031 | Nervous mechanisms of restraint water-immersion stress-induced gastric mucosal lesion |
| Q92159183 | Neutrophil-activating Protein Polymorphism of Helicobacter pylori Determines the Host Risk of Dyspepsia |
| Q58594791 | New Approaches to Diagnosis and Treatment of Functional Dyspepsia |
| Q58553837 | New classification Rome IV functional dyspepsia and subtypes |
| Q90429168 | New fecal test for non-invasive Helicobacter pylori detection: A diagnostic accuracy study |
| Q38977503 | Newest Drugs for Chronic Unexplained Nausea and Vomiting |
| Q38809157 | Novel Treatments for Cyclic Vomiting Syndrome: Beyond Ondansetron and Amitriptyline |
| Q58110565 | Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors |
| Q48020978 | Pathophysiological Abnormalities in Functional Dyspepsia Subgroups According to the Rome III Criteria |
| Q57819648 | Pathophysiology of Potassium-competitive Acid Blocker-refractory Gastroesophageal Reflux and the Potential of Potassium-competitive Acid Blocker Test |
| Q47622823 | Performance of an algorithm-based approach to the diagnosis and management of functional gastrointestinal disorders: A pilot trial. |
| Q64096479 | Personalized medicine in functional gastrointestinal disorders: Understanding pathogenesis to increase diagnostic and treatment efficacy |
| Q47639030 | Postprandial High-Resolution Impedance Manometry Identifies Mechanisms of Nonresponse to Proton Pump Inhibitors. |
| Q41073935 | Postprandial Symptoms Felt at the Lower Part of the Epigastrium and a Possible Association of Pancreatic Exocrine Dysfunction with the Pathogenesis of Functional Dyspepsia |
| Q92518776 | Postprandial Symptoms in Patients With Functional Dyspepsia and Irritable Bowel Syndrome: Relations to Ultrasound Measurements and Psychological Factors |
| Q98892453 | Predictive value of alarm symptoms in patients with Rome IV dyspepsia: A cross-sectional study |
| Q57215535 | Prevalence and Risk Factors of Functional Dyspepsia in Health Check-up Population: A Nationwide Multicenter Prospective Study |
| Q89686641 | Prevalence of Non-Celiac Gluten Sensitivity in Patients with Refractory Functional Dyspepsia: a Randomized Double-blind Placebo Controlled Trial |
| Q90382520 | Prevalence of Self-medication for Acid Peptic Disease amongst People of Manawa, Lahore |
| Q57688729 | Prokinetics for functional dyspepsia |
| Q94338346 | Prokinetics for functional dyspepsia |
| Q33836928 | Prokinetics for the treatment of functional dyspepsia: Bayesian network meta-analysis. |
| Q38875933 | Protein Kinase C Mediates the Corticosterone-induced Sensitization of Dorsal Root Ganglion Neurons Innervating the Rat Stomach |
| Q57689520 | Proton pump inhibitors for functional dyspepsia |
| Q36300366 | Proton pump inhibitors for functional dyspepsia |
| Q64282500 | Recent understanding of the pathophysiology of functional dyspepsia: role of the duodenum as the pathogenic center |
| Q44818920 | Relating gastric scintigraphy and symptoms to motility capsule transit and pressure findings in suspected gastroparesis |
| Q99564428 | Risk factors of Parkinson's disease: Simultaneous assessment, interactions and etiological subtypes |
| Q55527145 | Role of Gut Microbiota-Gut Hormone Axis in the Pathophysiology of Functional Gastrointestinal Disorders. |
| Q93043235 | Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome |
| Q55555758 | Role of the Duodenum in the Pathogenesis of Functional Dyspepsia: A Paradigm Shift. |
| Q56366234 | Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome |
| Q88886246 | Rome IV Diagnostic Questionnaire Complements Patient Assessment of Gastrointestinal Symptoms for Patients with Gastroparesis Symptoms |
| Q36170228 | Rumination syndrome: pathophysiology, diagnosis, and treatment |
| Q89613528 | Secretin effects on gastric functions, hormones and symptoms in functional dyspepsia and health: randomized crossover trial |
| Q33705886 | Self-rated health and functional capacity in individuals reporting overlapping symptoms of gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome - a population based study |
| Q93198215 | Sini-San Regulates the NO-cGMP-PKG Pathway in the Spinal Dorsal Horn in a Modified Rat Model of Functional Dyspepsia |
| Q41571545 | Sini-san improves duodenal tight junction integrity in a rat model of functional dyspepsia |
| Q64289372 | Sociedade Portuguesa de Cuidados Intensivos guidelines for stress ulcer prophylaxis in the intensive care unit |
| Q42620103 | Superior Mesenteric Artery Syndrome May Be Overlooked in Women with Functional Dyspepsia. |
| Q60923102 | Thailand Dyspepsia Guidelines: 2018 |
| Q42375228 | The Ameliorating Effect of Lactobacillus gasseri OLL2716 on Functional Dyspepsia in Helicobacter pylori-Uninfected Individuals: A Randomized Controlled Study |
| Q39411364 | The Application of the Rome IV Criteria to Functional Esophagogastroduodenal Disorders in Asia |
| Q90520407 | The Associations Among Symptoms, Quality of Life, and Gastric Emptying: An Unresolved Issue |
| Q57167488 | The Gut Microbiome in Adult and Pediatric Functional Gastrointestinal Disorders |
| Q48313861 | The NO/cGMP pathway in duodenal motor, mechano- and chemosensory responses to acid: A randomized, placebo-controlled study with sildenafil in healthy volunteers |
| Q91674741 | The Psychotic Impact of Helicobacter pylori Gastritis and Functional Dyspepsia on Depression: A Systematic Review |
| Q89964560 | The Role of Diet in Functional Dyspepsia Management |
| Q91635722 | The Role of GI Peptides in Functional Dyspepsia and Gastroparesis: A Systematic Review |
| Q49560611 | The association between adult-type hypolactasia and symptoms of functional dyspepsia |
| Q39154354 | The low-FODMAP diet in the management of functional dyspepsia in East and Southeast Asia |
| Q42367241 | The management of functional dyspepsia in clinical practice: what lessons can be learnt from recent literature? |
| Q42284202 | Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study |
| Q38743122 | Transient receptor potential vanilloid 4 (TRPV4) silencing in Helicobacter pylori-infected human gastric epithelium. |
| Q94093775 | UEG Week 2018 Poster Presentations |
| Q52923831 | Upper GI Disorders: Pathophysiology and Current Therapeutic Approaches. |
| Q37681281 | Utility of the wireless motility capsule and lactulose breath testing in the evaluation of patients with Parkinson's disease who present with functional gastrointestinal symptoms |
| Q90520522 | What Is Appropriate Upper Endoscopic Interval Among Dyspeptic Patients With Previously Normal Endoscopy? A Multicenter Study With Bayesian Change Point Analysis |
| Q34680985 | What Is New in Rome IV. |
| Q30235234 | What's new in Rome IV? |
| Q57287657 | Will MRI of gastrointestinal function parallel the clinical success of cinecardiac MRI? |
Search more.